JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Memory-improving Effects of Fermented Sea Tangle Saccharina japonica in Normal Mice
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Memory-improving Effects of Fermented Sea Tangle Saccharina japonica in Normal Mice
Ryu, Jehkwang; Jo, Young-Hong; Chang, Seong-Jun; Lee, Bae-Jin;
  PDF(new window)
 Abstract
Marine organisms are sources of many bioactive compounds, such as essential fatty acids, essential amino acids, vitamins, and minerals, making them useful candidates for the production of safe bioactive substances. They also synthesize glutamic acid, which can be used to produce γ-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system (CNS), via fermentation with Lactobacillus brevis BJ-20. This study investigated the degree to which fermented sea tangle (FST) inhibits enzymes such as acetylcholine esterase (AChE) and prolyl endopeptidase (PEP) and affects memory of normal mice using the T-maze test. FST inhibited more than 90% of AChE at 1 mg/mL and 50% of PEP at 8 mg/mL. Oral FST (100 mg/kg) significantly improved performance of normal mice on the T-maze. Therefore, sea tangle fermented with L. brevis BJ20 effectively contributes to memory improvement and might be a useful functional food ingredient.
 Keywords
Fermented sea tangle;AChE;PEP;T-maze test;Memory;
 Language
Korean
 Cited by
 References
1.
Alderson RF, Alterman AL, Barde YA and Lindsay RM. 1990. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 5, 297-306. http://dx.doi.org/10.1016/0896-6273(90)90166-D. crossref(new window)

2.
Aoyagi T, Nagai M, Ogawa K, Kojima F, Okada M, Ikeda T, Hamada M and Takeuchi T. 1991. Poststatin, a new inhibitor of prolyl endopeptidase, produced by Strptomyces viridochromogenes MH534-30F3. I. Txonomy, production, isolation, physico-chemical properties and biological activities. J Antibiot 44, 949-955. http://dx.doi.org/10.7164/antibiotics.44.949. crossref(new window)

3.
Ellman GL, Countney KD, Andress V and Featherstone RM. 1961. A new and rapid colorimetric determination acetylcholine esterase activity. Biochem Pharmacol 7, 88-95. http://dx.doi.org/10.1016/0006-2952(61)90145-9. crossref(new window)

4.
Buchet R and Pikula S. 2000. Alzheimer’s disease: Its origin at the membrane, evidence and questions. Acta Biochimica Polonica 47, 725-733.

5.
Choi MR, Lee MY, Hong JE, Lee JY, Chun JW, Kim TH, Shin HK and Kim EJ, 2012. The aqueous extract of Rubus coreanus Miquel improves scopolamine-induced memory impairment in ICR Mice. J Korean Soc Food Sci Nutr 41, 192-196. http://dx.doi.org/10.3746/jkfn.2012.41.2.192. crossref(new window)

6.
Colovic MB, Krstic DZ, Lazarevic-Pasti TD, Bondzic AM and Vasic VM. 2013 Acetylcholinesterase inhibitors: Pharmacology and Toxicology. Current Neuropharmacol 11, 315-335. http://dx.doi.org/10.2174/1570159X11311030006. crossref(new window)

7.
Deacon RMJ and Rawlins JNP, 2006. T-maze alternation in the rodent. Nature Protocols 1, 7-12. http://dx.doi.org/10.1038/nprot.2006.2. crossref(new window)

8.
Defelice FG and Ferreira ST. 2002. Physiopathological modulators and amyloid aggregation and novel pharmacological approaches in Alzheimer's disease. An Acad Bras Ciênc 74, 265-284. http://dx.doi.org/10.1590/S0001-37652002000200006. crossref(new window)

9.
Ikeya Y, Takeda S, Tunakawa M, Karakida H, Toda K, Yamaguchi T and Aburada M. 2004. Cognitive improving and cerebral protective effects of acylated oligosaccharides in Polygala tenuifolia. Biol Pharm Bull 27, 1081-1085. http://dx.doi.org/10.1248/ bpb.27.1081. crossref(new window)

10.
Jegal KH, Park SJ, Kim CY, Lee C, Park JH and Jang JH. 2010 Effect of Poria cocos on the scopolamine-induced memory impairment and its underlying molecular mechanism. Korean J Orient Physiol Pathol 24, 228-235.

11.
Jung YS, Park SJ, Kim JE, Yang SA, Park JH, Kim JH, Jhee KH, Lee SP and Lee IS. 2012. A comparative study of GABA, glutamate contents, acetylcholinesterase inhibition and antiradical activity of the methanolic extracts from 10 edible plants. Korean J Food Sci Technol 44, 447-451. crossref(new window)

12.
Kalueff A. and Nutt DJ. 1997. Role of GABA in memory and anxiety. Depression Anxiety 4, 100-110.

13.
Kang YM, Lee BJ, Kim JI, Nam BH, Cha JY, Kim YM, Ahn CB, Choi JS, Choi IS and Je JY. 2012. Antioxidant effects of fermented sea tangle (Laminaria japonica) by Lactobacillus brevis BJ20 in individuals with high level of γ-GT: a randomized, double-blind, and placebo-controlled clinical study. Food Chem Toxicol 50, 1166-1169. http://dx.doi.org/1016/j. fct.2011.11.026. crossref(new window)

14.
Kang YM, Woo NS and Seo YB. 2013. Effects of Lactobacillus brevis BJ20 Fermentation on the antioxidant and antiinflammatory activities of sea tangle Saccharina japonica and oyster Crassostrea gigas. Korean J Fish Aquat Sci 46, 359-364. http://dx.doi.org/10.5657/KFAS.2013.0359. crossref(new window)

15.
Kim JH, Kim SI and Song KS. 2001. Prolyl endopeptidase inhibitors from green tea. Arch Pharm Res 24, 292-296. http://dx.doi.org/10.1007/BF02975094. crossref(new window)

16.
Um MY, Ha TY, Seong KS and Kim YS. 2013. In vitro screening of the acetylcholinesterase inhibition, antioxidant activity, and neuronal cell protective effect of medicinal plant extracts. Korean J Food Preserve 20, 840-845. http://dx.doi.org/10.11002/ kjfp.2013.20.6.840. crossref(new window)

17.
Kook MC, Seo MJ, Cheigh CI, Pyun YR, Cho SC and Park H. 2010. Enhanced production of γ-aminobutyric acid using rice bran extracts by Lactobacillus sakei B2-16. J Microbiol Biotechnol 20, 763-766. http://dx.doi.org/10.4014/jmb.0911.11016.

18.
Kasa P, Rakonczay Z and Gulya K. 1997. The cholinergic system in Alzheimer's disease. Prog Nuurobiol 52, 511-535. http://dx.doi.org/10.1016/S0301-0082(97)00028-2. crossref(new window)

19.
Kwak JH, Jeong CH, Kim JH, Choi GN, Shin YH, Lee SC, Cho SH, Choi SG and Heo HJ. 2009. Acetylcholiesterase inhibitory effect of green tea extracts according to storage condition. Korean J Food Sci Technol 41, 435-440.

20.
Kwon YR, Cho SM, Hwang SP, Kwon GM, Kim JW and Youn KS. 2014. Antioxidant, physiological activities, and acetylcholinesterase inhibitory activity of Portulaca oleracea extracts with different extraction methods. J Korean Soc Food Sci Nutr 43, 389-396. http://dx.doi.org/10.3746/jkfn.2014.43.3.389 crossref(new window)

21.
Lee BJ, Kim JS, Kang YM, Lim JH, Kim YM, Lee MS, Jeong MH, Ahn CB and Je JY. 2010. Antioxidant activity and γ-aminobutyric acid (GABA) content in sea tangle fermented by Lactobacillus brevis BJ20 isolated from traditional fermented foods. Food Chemistry 122, 271-276. http://dx.doi.org/10.1016/j.foodchem.2010.02.071. crossref(new window)

22.
Lee HJ, Kim JH, Lee JH, Kim JS, Kwak ST, Lee KB, Song KS, Choi BW and Lee BH. 1999. Inhibitory activities of seaweeds on prolyl endopeptidase, tyrosinase and coagulation. Korean J Pharmacogn 30, 231-237

23.
Lee KH, Lee HJ and Park HI. 1997. Screening of prolyl endopeptidase inhibitors from natural products. Yakhak Hoeji 41, 153-160.

24.
Lee SH, Park HJ, Cho YS, Chung IK and Song KS. 2003. Screening of prolyl endopeptidase inhibition from Korean natural foods. J Korean Soc Food Sci Nutr 32, 971-975. http://dx.doi.org/10.3746/jkfn.2003.32.7.971. crossref(new window)

25.
Mannisto PT, Venalainen J, Jakanen A and Garcia-Horsman JA. 2007. Prolyl oligopeptidase: a potential target for the treatment of congnitive disorders. Drug New Perspect 20, 293-305. http://dx.doi.org/10.1358/dnp.2007.20.5.1120216. crossref(new window)

26.
McAllister AK, Katz LC and Lo DC. 1999. Neurotrophins and synaptic plasticity. Annu Rev Neurosci. 22, 295-318. http://dx.doi.org/10.1146/annurev.neuro.22.1.295 crossref(new window)

27.
Mehta M, Adem A and Sabbagh M. 2012. New acetylcholinesterase inhibitors for Alzheimer's disease. Int J Alzheimers Dis 2012, 1-8. http://dx.doi.org/10.1155/2012/728983. crossref(new window)

28.
Murray KD, Gall CM, Jones EG and Isackson PJ. 1994. Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease. Neuroscience 60, 37-48. http://dx.doi.org/10.1016/0306-4522(94)90202-X. crossref(new window)

29.
Park HJ, Lee MS, Shim HS, Lee GR Chung SY, Kang YM, Lee BJ, Seo YB, Kim KS and Shim I. 2016. Fermented Saccharina japonica (Phaeophyta) improves neuritogenic activity and TMT-induced cognitive deficits in rats. Algae 31, 1-12. http://dx.doi.org/10.4490/algae.2016.31.11.10. crossref(new window)

30.
Schneider JS, Giardiniere M and Morain P. 2002. Effects of the prolyl endopeptidnase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys. Neuropsychopharmacology 26, 176-182. http://dx.doi.org/10.1038/S0893- 133X(01)00307-4. crossref(new window)

31.
Shinoda M, Toide K, Ohsawa I and Kohsaka S. 1997. Specific inhibitor for prolyl endopeptidase suppresses the generation of amyloid beta protein in NG 108-15 cells. Biochem Biophys Res Commun 27, 641-645. http://dx.doi.org/10.1006/bbrc.1997.6730. crossref(new window)

32.
Shoji H, Hagihara H, Takao K, Hattori S and Miyakawa T. 2012. T-maze vorced alternation and left-right discrimination tasks for assessing working and reference memory in mice. J Vis Exp 60, e3300. 10.3791/3300. crossref(new window)

33.
Toda S, Obi Y, Numata K, Hamagishi Y, Tomita K, Komiyama N, Kotake C, Furumai T and Oki T. 1992. Eurystatins A and B, new prolyl endopeptidase inhibitors, I. Taxonomy, production, isolation and biological activities. J Antibiot 45, 1573-1579. http://doi.org/10.7164/antibiotics.45.1573. crossref(new window)

34.
Talesa VN. 2001. Acetylcholinesterase in Alzheimer's disease. Mech Ageing Dev 122, 1961-1969. http://dx.doi.org/10.1016/S0047- 6374(01)00309-8. crossref(new window)

35.
Toide K, Shinoda M, Fujiwara T and Iwamoto Y. 1997. Effect of nobel prolyly endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats. Pharmacol Biochem Behav 56, 427-434. http://dx.doi.org/10.1016/S0091- 3057(96)00238-9. crossref(new window)

36.
Yuk DY, Kim TI, Park SG, Park HK, Yoon YK and Hong JT. 2007. Improvement of memory impairment by L-theanine through inhibition of acetylcholinesterase activity in mice. Yakhak Hoehi 51, 409-414.

37.
Toda S, Obi Y, Numata K, Hamagishi Y, Tomita K, Komiyama N, Kotake C, Furumai T and Oki T. 1992. Eurystatins A and B, new prolyl endopeptidase inhibitors, I. Taxonomy, production, isolation and biological activities. J Antibiot 45, 1573-1579. http://dx.doi.org/10.7164/antibiotics.45.1573. crossref(new window)

38.
Talesa VN. 2001. Acetylcholinesterase in Alzheimer's disease. Mech Ageing Dev 122, 1961-1969. http://dx.doi.org/10.1016/S0047- 6374(01)00309-8. crossref(new window)

39.
Toide K, Shinoda M, Fujiwara T and Iwamoto Y. 1997. Effect of nobel prolyly endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats. Pharmacol Biochem Behav 56, 427-434. http://dx.doi.org/10.1016/S0091-3057(96)00238-9. crossref(new window)

40.
Yuk DY, Kim TI, Park SG, Park HK, Yoon YK and Hong JT. 2007. Improvement of memory impairment by L-theanine through inhibition of acetylcholinesterase activity in mice. Yakhak Hoehi 51, 409-414.